This page shows the latest Mundipharma news and features for those working in and with pharma, biotech and healthcare.
Other pharma Gold winners included ALK, Heart UK, Immunocore, Janssen, Mundipharma, Novo Nordisk and Santen. ... Craft Award for Events and Exhibitions: Envision Pharma Group for Mundipharma with support from woolley pau gyro.
Mundipharma and Kings College London both won a Gold and a Silver.
Other Gold winners included Aspen, Boeringher Ingelheim, Galderma, Johnson &Johnson, Mundipharma, Napp, Novartis, PTC Therapeutics, Shire, Teva, Tillotts Pharma and ViiV. ... Craft Award for Interactive Communications: Havas Lynx for Teva Pharmaceuticals.
GlobalData predicts Trazimera can earn $9m in its first year, far behind the forecast 12 month totals for Celltrion and Mundipharma’s Herzuma ($59m), Amgen’s Kanjinti ($33m), and Samsung Bioepsis
period. A number of biosimilar versions of the drug hit European markets last year, including Celltrion's Truxima, (pictured), marketed by Mundipharma and other firms across the region, and this year
Mundipharma has strengthened its partnership with biopharmaceutical group Celltrion Healthcare by securing rights to its trastuzumab biosimilar. ... As per terms of the deal, Mundipharma - a global network of privately owned independent companies - has
More from news
Approximately 9 fully matching, plus 47 partially matching documents found.
Finally it is always encouraging to see medium size companies like Mundipharma and Jazz finding and licensing new product opportunities. ... Mundipharma built its oncology franchise following the acquisition of an old anti-cancer drug and the deal to
Mundipharma’s Will Dunlop on a new framework to guide development programmes to a better destination. ... programme,” says Will Dunlop, head of market access for Mundipharma International, who has been developing the project over the last five years.
For example in Europe both Pfizer (Hospira) in 2009 and Mundipharma in 2014 have rights to Celltrion's infliximab.
This first infliximab biosimilar was developed and manufactured by Celltrion and is marketed by various partners, notably Hospira under the brand name Inflectra and Mundipharma as Remsima.
Divestment of US rights. 1, 050. Esteve/ Mundipharma. Discovery and development of next generation pain products including E-52862 in P2 for neuropathic pain.
More from intelligence
Approximately 2 fully matching, plus 7 partially matching documents found.
Latest movers in pharma. Mundipharma hires new SVP business development and strategic partnerships. ... Mundipharma has named Marco Cerato as its senior vice president, business development and strategic partnerships.
His new role will see him take responsibility for strengthening Mundipharma’s network in Europe and focus on its alliances. ... Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.
His new role will see him take responsibility for the IT services provided to Mundipharma’s global network of associated companies. ... My goal is to ensure that the Mundipharma network has the technology support it needs to lead the charge in pharma
Moves from Mundipharma to take up managing director role. Napp Pharmaceuticals has appointed Hywel Day as its new managing director. ... It’s a return to Napp for Day, who spent 10 years at Napp from 2003, before moving to Mundipharma.
Alberto Martinez joins from Mundipharma. UK-based Napp Pharmaceuticals has appointed Alberto Martinez as the company's new managing director. ... Martinez's previous experience includes time as marketing manager at Mundipharma's international operations
More from appointments
Approximately 2 fully matching, plus 6 partially matching documents found.
Copywriting. AKLRD | A Life in a Day | Allergan | Amgen | Arquer Diagnostics | Bleepa | Boehringer Ingelheim | Galapagos | Inivata | Janssen | Kantar | Maxwellia | Macmillan | Mundipharma | Norgine | Novo Nordisk | Pfizer | Roche | Sanofi | Santen |
Congratulations to our exceptionally talented team that, in close partnership with Mundipharma and supported by Woolley Pau, conceptualized this novel and impactful way to engage a larger audience with this important ... Nick Morgan, Head of Specialist
collaboration with Mundipharma.
Commissioned by Mundipharma, the paper is titled ‘Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral
at global and local affiliate level for clients such as Merck Serono, Lundbeck, Pfizer and MundiPharma.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...